Legislation roundup: Strategic investment, delisting and pharma
Aug 2, 2018
Requirements for strategic investment in A-share companies are lowered, major violations of the law are specified in the delisting system and MAHs may entrust the sale of pharmaceuticals.
X
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
Capital Markets
This premium content is reserved for China Law & Practice Subscribers.
A Premium Subscription Provides:
A database of over 3,000 essential documents including key PRC legislation translated into English
A choice of newsletters to alert you to changes affecting your business including sector specific updates
Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment